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Abstract
Background
Snake venoms contain many proteinaceous toxins that can cause severe pathology and
mortality in snakebite victims. Interestingly, mRNA encoding such toxins can be recovered
directly from venom, although yields are low and quality is unknown. It also remains unclear
whether such RNA contains information about toxin isoforms and whether it is representa-
tive of mRNA recovered from conventional sources, such as the venom gland. Answering
these questions will address the feasibility of using venom-derived RNA for future research
relevant to biomedical and antivenom applications.
Methodology/Principal Findings
Venom was extracted from several species of snake, including both members of the Viperi-
dae and Elapidae, and either lyophilized or immediately added to TRIzol reagent. TRIzol-
treated venom was incubated at a range of temperatures (4–37°C) for a range of durations
(0–48 hours), followed by subsequent RNA isolation and assessments of RNA quantity and
quality. Subsequently, full-length toxin transcripts were targeted for PCR amplification and
Sanger sequencing. TRIzol-treated venom yielded total RNA of greater quantity and quality
than lyophilized venom, and with quality comparable to venom gland-derived RNA. Full-
length sequences from multiple Viperidae and Elapidae toxin families were successfully
PCR amplified from TRIzol-treated venom RNA. We demonstrated that venom can be
stored in TRIzol for 48 hours at 4–19°C, and 8 hours at 37°C, at minimal cost to RNA quality,
and found that venom RNA encoded multiple toxin isoforms that seemed homologous (98–
99% identity) to those found in the venom gland.
Conclusions/Significance
The non-invasive experimental modifications we propose will facilitate the future investiga-
tion of venom composition by using venom as an alternative source to venom gland tissue
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for RNA-based studies, thus obviating the undesirable need to sacrifice snakes for such
research purposes. In addition, they expand research horizons to rare, endangered or pro-
tected snake species and provide more flexibility to performing fieldwork on venomous
snakes in tropical conditions.
Author Summary
Venomous snakes use venom proteins to capture their prey. When a human is bitten,
these proteins cause severe pathology and often lead to death, disability or other serious
complications. Understanding the composition of snake venom is essential not only for
developing more effective snakebite treatments but also for acquiring a better understand-
ing of the biology that underpins this extraordinary group of animals. Currently, to
determine the genes expressing these venom proteins requires sacrificing the snake and
isolation of mRNA from the venom gland. This is undesirable for ethical reasons and lim-
its the scope of this type of research. Encouragingly, we and others have recently demon-
strated that mRNA encoding venom proteins can be obtained from lyophilized snake
venom. In this study we show that venom RNA in these samples is in fact considerably
degraded. We report a protocol to improve the yield of undegraded RNA (immediate
addition of TRIzol reagent to the venom). We also explored the limitations of this new
protocol, in terms of time and temperature applicability. We then showed that consider-
able isoform diversity can be captured from snake venom RNA, and show that the iso-
forms identified are identical to those found in the venom gland of sacrificed snakes. Our
findings provide protocols enabling researchers working in a range of fields to consider-
ably expand the scope of their research because venom composition data can now be
reliably acquired from venom which in turn can be obtained from live snakes without
harming the animals.
Introduction
Venomous snakes are highly proficient predators that occupy almost all natural habitats: from
desert to tropical jungle and all terrestrial environments within this range, as well as marine
and freshwater bodies [1,2]. The evolution of venom proteins that cause rapid cardiovascular
or neurological immobilisation and death of their prey has underpinned the predatory success
of these limbless animals [2]. Snakebites on humans, on the other hand, are accidents of ‘last-
resort’ defence against perceived aggression but often carry extreme consequences for the vic-
tims—venomous snakes kill over 94,000 people annually [3], most residing in remote, deeply-
disadvantaged rural tropical communities [4]. Defining the protein composition of snake ven-
oms is therefore vital for the development of new snakebite therapies (antivenom) and funda-
mental to basic research on venom evolution and bioactivity.
Each venomous snake species/genus has evolved a distinct repertoire of venom proteins to
achieve their predatory objective [5]. Thus, the venom protein composition profile varies at
every taxonomic level [6,7] and even within a species as a result of a variety of factors, including
geographical origin [7–9], gender [10,11], diet [12] and age [13–15]. Some, typically the most
toxic, venom protein groups show marked over-representation [6] and isoform diversity. For
example, three-finger neurotoxins that can account for over 70% of cobra venom proteomes
[16] are encoded by a very substantial number of sequence-distinct isoforms [17,18]. Venom
Stabilising the Integrity of mRNA in Snake Venom
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0004615 June 9, 2016 2 / 17
transcriptomes are essential pre-requisites for research studies on, for example, the evolution-
ary forces driving venom protein composition [6,17,19–22] and next generation therapies [23].
The transcriptomes used in all these studies were derived from mRNA isolated from venom
glands dissected from snakes that had to be sacrificed for this purpose. Aside from ethical
detractions, our current dependence upon venom glands for generating transcriptomes limits
our research horizons to those snake species that (i) can be readily acquired and maintained in
the few research establishments with the requisite herpetological facilities and expertise or (ii)
can be collected in the field. It also excludes research on the numerous snake species that are
protected by national and/or international legislation (e.g., the Convention on the International
Trade with Endangered Species, CITES), species that are rare/difficult to find in the field, and
species that do not survive long in captivity. Furthermore, current methods do not permit stud-
ies on, for example, ontogenetic changes in venom protein composition within the life-span of
an individual snake.
Shaw’s group in Belfast were the first to document that mRNA encoding toxins can be
recovered from the venom or skin secretions of several species [24,25], and suggested that
snake venom might be an ethically-attractive alternative to venom glands for preparing tran-
scriptomes. The presence of nucleic acids in venom has since been exploited by using PCR-
amplification of DNA in venom for snake species taxonomy [26] and to monitor gene expres-
sion dynamics over the course of venom replenishment in the venom gland [27]. The objective
of the work reported herein was to examine the stability of venom mRNA recovered under
tropical field conditions, and to assess the extent to which venommRNA represents the isofor-
mic diversity reported in venom gland transcriptomes.
Methods
Ethics Statement
All snakes were maintained in individual cages within the temperature, humidity and light-
controlled environment of the herpetarium of the Alistair Reid Venom Research Unit, Liver-
pool School of Tropical Medicine. The facility and its protocols for the expert husbandry of the
snakes are regularly inspected and approved by the UK Home Office and the LSTM Animal
Welfare and Ethical Review Board.
Biological Material
Venom was extracted and pooled from (i) ten, wild-caught, Nigerian puff adders (Bitis arie-
tans), (ii) a single, captive bred, adult specimen of the intermediate shield-nose snake (Aspide-
laps scutatus intermedius), (iii) six Angolan coral snakes (Aspidelaps lubricus cowlesi), (iv)
four cape coral snakes (Aspidelaps lubricus lubricus) and (v) a single monocled cobra (Naja
kaouthia). The number of snakes used in this study was the maximum possible given the
limited availability of these animals in our facility. We also used data from a separate study
wherein venom glands were dissected from terminally-anaesthetised specimens of B. arietans,
and immediately snap frozen in liquid nitrogen.
RNA Isolation and Quality Analysis
Venom. To assess the potential benefit of mRNA-stabilising reagents, we added TRIzol
reagent (Life Technologies) to the venoms at a ratio of 5:1 as soon after venom extraction as
safety permitted. RNA was isolated from the venom using the TRIzol Plus RNA Purification
System following the manufacturer’s instructions (unless stated otherwise). To assess the effect
of storage time and temperature on venom RNA stability, a sample of the B. arietans venom/
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TRIzol mixture was aliquoted into three equal volumes. Each sample was incubated at one of
three temperatures: 4°C, 19°C or 37°C and RNA isolated (as per above) after 8, 24 or 48 hours.
A sample of venom was also conventionally lyophilized and stored at 4°C until required. Each
aliquot equated to 500 μL of liquid venom (equivalent to 124.66 mg lyophilized venom). All
other venom samples had TRIzol added at a ratio of 5:1 and were processed using the TRIzol
Plus RNA Purification System. All samples were DNase treated on column during the TRIzol
Plus purification system protocol (On-Column PureLink DNase; Life Technologies) and total
RNA was eluted in 30 μL nuclease free water (QIAGEN).
Venom gland. RNA from venom glands provided both the control for the venom RNA
samples and the source for the transcriptomes from which the C-type lectin transcripts were
assembled. Bitis arietans venom gland tissue (272 mg) was immediately homogenised under
liquid nitrogen using a pestle and mortar and then a TissueRuptor (QIAGEN). Samples were
DNase treated (On-Column PureLink DNase; Life Technologies) and total RNA was extracted
and eluted in 30 μL nuclease free water (QIAGEN) using the TRIzol Plus RNA Purification
System protocol. Venom gland transcriptomes were sequenced, assembled and annotated as
previously described (Sanger sequenced EST transcriptome [28]; second generation Illumina
transcriptome [29]).
Quality Analysis
The quality and quantity of RNA isolated from conventionally lyophilized (VLYO) or TRIzol
treated (VTRZ) venom samples (including after variant storage temperature and times), was
compared using a Bioanalyzer (Agilent, UK). The Bioanalyzer uses the entire electrophoretic
trace (electropherogram) of the RNA sample including the presence/absence of degradation
products in a sample concentration-independent manner. We added 1 μL of each total RNA
sample into Agilent RNA 6000 Nano/Pico Chips (following the manufacturer’s instructions)
and then inserted them into the Agilent 5000 Bioanalyzer for analysis. The quality of the two
ribosomal RNA peaks are used as a reliable indicator of the integrity of the other RNAmole-
cules. Calculations are based upon quantitating the amount of fluorescent dye intercalated
within the RNA, thereby efficiently discounting contaminants such as phenol (a common carry
over from RNA isolation preparations) that can vitiate the accuracy of standard UV-spectrome-
try. Agilent’s RNA 2100 Expert software was used to calculate total RNA concentration and
assign a RNA integrity number (RIN), which range from 1–10; with 10 being completely unde-
graded, and 1 being completely degraded RNA [30].
Complementary DNA (cDNA) Synthesis
We isolated mRNA from 2 μL of each total RNA sample using oligo(dT) primers and pro-
cessed it into single-stranded cDNA using the Superscript III first-strand synthesis system
(Invitrogen). Each single-stranded cDNA sample was treated with RNase H to eliminate con-
taminating RNA. This process provided a stable and reproducible copy of each venom/venom
gland RNA preparation.
PCR Amplification and Sequencing
Bitis arietans primer design. Primers complimentary to genes encoding B. arietans serine
proteases (SP), snake venom metalloproteinases (SVMPs), L-amino acid oxidases (LAO), C-
type lectins (CTL), vascular endothelial growth factors (VEGF) and aminopeptidases (AMP)
were designed (Table 1) and synthesized commercially (Sigma Aldrich). These gene families
were selected as they collectively represent major and minor venom protein components, as
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well as long and short transcripts, and thus served to explore the limits of our experimental
approach. The primer design was based upon our B. arietans transcriptome data [29].
Elapid three-finger toxin primer design. To assess whether mRNA recovered from
venom includes representation of transcripts encoding multiple diverse isoforms, we generated
primers complementary to the three-finger neurotoxin (3FTX) (Table 2) gene family which is
abundantly expressed in the venom glands of elapid snakes (e.g., [16,17]), as well as group 1
phospholipase A2 (PLA2), CTLs, SVMPs and Kunitz-type serine protease inhibitors (KSPI) (S1
Table). However, at the outset of this study we were unsure of the gene isoform diversity of
Aspidelaps spp. (the objective of the experiment). We therefore decided to pool the venom
RNA of N. kaouthia (that has known venom gland gene isoform diversity) with that from A. s.
intermedius, A. l. cowlesi, and A. l. lubricus, thereby ensuring the presence of multiple gene tar-
gets for PCR amplification. Furthermore, since there are no published genes encoding Aspide-
laps 3FTXs, PLA2s, CTLs, SVMPs or KSPIs, our primers were designed upon conserved
sequences flanking the open reading frames of published sequences from several species of the
genus Naja (cobras),Walterinnesia aegyptia (desert black cobra) and Ophiophagus hannah
(king cobra). These snakes are the closest phylogenetic relatives of the genus Aspidelaps [31].
To maximise the likelihood of PCR success, each forward primer was used in combination
with each reverse primer to identify the best combination.
PCR conditions. One μL of venom cDNA was added to 5 μL 10 x PCR buffer, 5 μL 2 mM
dNTP mixture (Fisher Scientific), 2.5 μL 10 μM forward primer, 2.5 μL 10 μM reverse primer,
1 μL DreamTaq polymerase (Life Technologies) and 33 μL nuclease-free H2O (QIAGEN) to a
final volume of 50 μL. PCR experiments were performed using a Techne TC-512 thermal
cycler. Touchdown PCR conditions were as follows: Initial denaturation at 94°C for 3 min.
Denaturing at 94°C, 30 sec; annealing temperature gradient 66–50°C, 1 min (-1.6°C/cycle);
extension at 72°C, 1 min; 10 cycles. Denaturing at 94°C, 30 sec; annealing at 50°C, 1 min; exten-
sion at 72°C, 1 min; 25 cycles. Final extension at 72°C for 10 min. Amplicons were visualised
on a 1% agarose in TBE gel, and analysed using the Bio-Rad Gel Doc System and Image Lab
Software (Bio-Rad).
Table 1. Bitis arietans primers.
Venom gene Forward primer Reverse primer Length of PCR product (base pairs)
AMP TTGTGGAGTGGTAATTGCG AGCCATTCTATGTTGCTCTT 2741
SVMP CTCCAAAATGATCCAAGTTCTC ATTTGGAAAAGGAAGCATGG 1880
LAO ATTCCCATCCACAATCTTC CGACATGTTTTGGCTGATATAC 1693
VEGF GAGAGTAGACCGCAGGGGAACG CAAAATGGCAAACAGGGAGATGAA 934
SP GGATCCATGGTGCTGATCAGAGTG CTCGAGTCACCGGGGGCAAGTCGC 782
CTL CTGCCGGGAAGGAAGGAAGACCAT GAGCGAAGGGGGCAGAGCAGAGAT 589
doi:10.1371/journal.pntd.0004615.t001
Table 2. Elapid three-finger toxin PCR primers.
List of forward primers List of reverse primers
TCCAGAAAAGATCGCAAGATGA CTAATTGTTGCATTTTTCTG
TCCGAAAAAGATCGCAAGATGA CTATAGGTTGCATTGGTCTGTT
TCCGTTGCTGTCGGCAAGATGA CTCAAGGAATTTAGCCACTCGT
ATGAAAACTCTGCTGCTGACCT AAACTCAAGGAATTTAGCCACT
GAATTTAGACATTATCAGTTG
CTAATTGTTGCATCTGTCTGTT
TCAGTTGCATCTGTCTGTATTG
doi:10.1371/journal.pntd.0004615.t002
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PCR amplicon sequencing. Bitis arietans amplicons, generated from highly stringent,
gene-specific primers for SVMP, LAO, SP, VEGF and AMP, were submitted for Sanger
sequencing (Beckman Coulter Inc., UK). The amplicons from the pooled elapid venoms were
generated with less species- and gene-specific primers and therefore were likely to contain
divergent sequences. Since we sought to capture this diversity, we purified amplicons from
each PCR reaction from the agarose gel using the Promega Wizard Kit (Promega), cloned these
into pCR2.1-TOPO vectors (Life Technologies), transformed chemically competent E. coli
(One Shot, Invitrogen, UK) to amplify the recombinant plasmids, and submitted the purified
plasmids (Miniprep Spin Kit, QIAGEN, UK) for sequencing as above. This was also completed
for the B. arietans venom CTL amplicons.
Bioinformatics
Sequencing files were trimmed of vector sequence and base calls with<30 PHRED scores
using SeqTrace [32], translated using MEGA6 version 6.06 [33] and aligned using the Muscle
alignment software and default settings [34]. Alignment figures were generated using BOX-
SHADE v3.21 using default settings.
Results
TRIzol Prevents Rapid Degradation of RNA in Bitis arietans Venom
Samples
We first tested the quality of RNA recovered from lyophilized venom samples (VLYO) because
most venom collections, including the samples used in all previous publications on venom
mRNA, are/will be prepared in this manner (extracted venom is frozen for 3+ hours and then
lyophilized into a dehydrated powder). The RIN number of VLYO was 4.6 (Fig 1A), indicating
that considerable, but not complete, degradation had occurred. This was unexpected because
the recovery of mRNA from venom in earlier PCR-based reports including our own [24,27],
had suggested that venom mRNAmust be unusually stable since mRNA is a notoriously fragile
biomolecule.
As a consequence of this new observation, we next examined the integrity of RNA from
venom samples to which we had added the RNA-stabilising agent TRIzol within seconds of the
extraction. These TRIzol-treated venom samples (VTRZ) had an RIN number of 7.7 (Fig 1A),
indicating that TRIzol treatment had substantially reduced RNA degradation. As a means of
comparison, total RNA isolated from the venom gland of B. arietans had an RIN number of 7.9
(Fig 1B), indicating that the total RNA obtained from the VTRZ was, in terms of total RNA
integrity, comparable with that isolated from snap-frozen venom gland tissue.
The electropherograms of the total RNA isolated from VTRZ and the venom gland (Fig 1A
and 1B; red lines) show nearly identical and undegraded 18S and 28S ribosomal RNA peak pro-
files. In comparison, the ribosomal peak profiles for the VLYO total RNA sample (Fig 1A; blue
line) were only marginally above baseline. The disparity between the ribosomal peak profiles
from the VTRZ and VLYO samples demonstrates that substantial ribosomal RNA degradation
has occurred in the VLYO RNA sample, and that this observation is not a function of the low
amount of RNA in the VLYO RNA sample.
Addition of TRIzol Improves the Quantity of RNA That Can Be
Recovered from Venom
Consistent with the RNA quality analysis, the total yield of RNA (Fig 1) obtained from VTRZ
(27 ng) was substantially greater than that from the same amount of VLYO sample (5 ng).
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Nevertheless, these quantities of venom RNA are 1000-fold less than that obtained from
venom gland tissue (35 μg from 272 mg of tissue). Current Next Generation Sequencing (NGS)
technologies routinely require greater than 1 μg total RNA as a starting point. Thus, although
the total RNA obtained from VTRZ is of sufficient quality, there is insufficient quantity of total
RNA for standard (non-PCR amplified) transcriptome NGS.
Greater Abundance of Full-Length Transcripts Recovered from the
Lyophilized and TRIzol-Treated Venom RNA Samples
The Bioanalyzer results suggest that total RNA is largely undegraded in VTRZ, but they provide
no indication as to the quality/protein-encoding validity of the underlying mRNA. To investi-
gate this, we designed primers to PCR-amplify full-length transcripts encoding B. arietans
venom proteins from the VLYO and VTRZ samples. We selected toxin sequence templates that
we had verified as differing with respect to transcript size and proportional representation [29],
i.e. SVMP, LAO, SP, VEGF and AMP.
This PCR experiment amplified intact full-length transcripts for each toxin family from
both B. arietans VLYO and VTRZ cDNA (Fig 2). Importantly however, the intensity of ampli-
con bands for VLYO was markedly reduced in comparison to that of the VTRZ cDNA. This
Fig 1. Quantitative and qualitative analysis ofBitis arietans total RNA isolated from lyophilized
venom, TRIzol-treated venom and venom gland. (A) Lyophilized (VLYO, blue line), TRIzol-treated (VTRZ,
red line) venom and (B) venom gland tissue. The y-axis is an arbitrary unit of fluorescence, and the x-axis
shows the nucleotide length of the RNA. Note that the venom (A) and venom gland (B) electropherograms
are presented with considerably different y-axis scale values reflecting the amount of RNA in the samples.
RNA Integrity Number (RIN) and yield are shown as inserts. Key: venom gland (VG), venom (V), lyophilized
(LYO), TRIzol-treated (TRZ).
doi:10.1371/journal.pntd.0004615.g001
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Fig 2. PCR amplification of Bitis arietans genes of distinct size and proportional representation from
VLYO and VTRZ cDNA. Key: L-amino acid oxidase (LAO), snake venommetalloproteinase (SVMP), vascular
endothelial growth factor (VEGF), serine protease (SP) or aminopeptidase (AMP). Molecular weight markers
are shown on the left (base pairs).
doi:10.1371/journal.pntd.0004615.g002
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result reinforces the Bioanalyzer results indicating that the underlying mRNA in VTRZ is less
degraded than that isolated from VLYO.
The Effects of Time and Temperature Storage Conditions on the
Acquisition of Full-Length Transcripts from the Lyophilized and TRIzol-
Treated Venom RNA Samples
Having shown the benefit of TRIzol-treating venom to acquire undegraded full-length toxin
transcripts, we next explored the effects of storing VTRZ samples at different temperatures (19
or 37°C) and for different durations (8, 24 and 48 hours) than those used above (4°C and 0
hours) to determine if the TRIzol-treatment protocol was suited to recovering RNA from ven-
oms collected under field conditions.
Total RNA integrity analysis. Bioanalyzer electropherograms for total RNA isolated from
VTRZ after storage at all time and temperature conditions tested show distinct ribosomal peaks
(Fig 3A, 3B and 3C) and in all cases these peaks were more defined than in those observed for
VLYO (red) samples. The quantity of total RNA recovered from VTRZ samples decreased with
extended storage periods and for all storage temperatures (Fig 3D, 3E and 3F, left axis). Again,
in all cases the RNA yield from VTRZ was considerably greater than that obtained from VLYO.
Interestingly, the quality of the total RNA, as indicated by the RIN number (Fig 3D, 3E and 3F,
right axis), did not change substantially for any time point or incubation temperature, and in
all cases the quality of the total RNA recovered was substantially higher than that from VLYO.
mRNA integrity analysis. We used the same PCR-amplification protocol as above to
assess the quality of mRNA in these variant time and temperature-storage venom samples (Fig
4). Treatment of venom with TRIzol preserved the quality of mRNA in venom, irrespective of
duration and temperature of storage: Each amplicon encoded full-length transcripts, and with
an abundance that far exceeded that of the VLYO sample. Slight variability in amplicon intensity
was detectable with 37°C storage showing reduced intensity relative to other temperatures. The
exception to this rule was AMP, where the amplicon observed after 8 hours at 37°C was barely
visible, yet an amplicon was observed in VLYO, suggesting that an increased temperature had
resulted in the degradation of this specific transcript.
Acquisition of Multiple, Diverse Transcripts from the TRIzol-Treated
Venom RNA Samples
The most pathogenic Viperidae and Elapidae venom protein families typically exhibit the
greatest gene isoform diversity and numerical representation in venom gland transcriptomes
[17,28,35]. Accurately acquiring this isoform diversity poses perhaps the greatest challenge to
using venom RNA as an alternative resource to venom glands for generating accurate, compre-
hensive transcriptomes.
To test whether this isoform diversity could be recovered from venom RNA, and to attempt
the recovery of genes encoding the typically low molecular weight elapid venom proteins from
venom mRNA, we prepared VTRZ samples from the pooled elapid venom. Here, we PCR-
amplified genes encoding the family of three-finger toxins because this gene family exhibits
very considerable isoform diversity in the venom of many elapid snake species [17,18,36]. The
elapid venom was treated as above for B. arietans, and the resultant cDNA subjected to PCR-
amplification with a matrix of primers (Table 2) representing the range of sequences flanking
the open reading frame of the 3FTX family in other elapid species. The PCR amplicons were
sub-cloned into E. coli and purified plasmids sequenced.
Using this approach we identified 81 unique 3FTX transcripts from the elapid venom
(Fig 5). Consistent with other highly diverse snake venom gene families, the alignment of
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these new translated 3FTX transcripts reveals a highly (but not completely) conserved cyste-
ine scaffold (consistent with previously described cysteine patterns), variable non-structural
regions, and includes putative neurotoxins, muscarinic toxins and cytotoxins [18]. Many
other isoforms were also identified for the PLA2, CTL, SVMP and KSPI venom protein fami-
lies (S1 Fig).
Fig 3. Quantitative and qualitative analysis of Bitis arietans total RNA isolated from VTRZ for a range of TRIzol storage times
and temperatures. Electropherograms for total RNA isolated from the venom of B. arietans after incubation in TRIzol at either 4°C
(A), 19°C (B) or 37°C (C) for 0 hours (dark blue), 8 hours (green), 24 hours (aqua), 48 hours (purple) or after lyophilization (red). The y-
axis is an arbitrary unit of fluorescence, and the x-axis shows the nucleotide length of the RNA. Total RNA yield (blue columns) and
RNA Integrity Number (orange dots) after incubation at 4°C (D), 19°C (E) or 37°C (F).
doi:10.1371/journal.pntd.0004615.g003
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Sequence Comparison of C-Type Lectin Sequences Obtained Using a
Variety of Techniques from Varied Sources
To demonstrate that the VTRZ RNA comprises the same range of isoforms obtained from (i)
different sequencing techniques, (ii) from venom glands and (iii) from Viperidae venoms, we
compared PCR-derived B. arietans CTL genes obtained from VTRZ RNA to those obtained
from venom gland samples (a) after PCR amplification, (b) as Expressed Sequence Tags (EST)
from a cDNA library, and (c) as NGS sequences. As anticipated, the VTRZ CTL sequences
included analogues (98–99% nucleotide sequence identity) of the isoforms recovered from
Fig 4. PCR amplification of Bitis arietans genes from VTRZ after incubation with TRIzol for a range of storage times and
temperatures and VLYO. L-amino acid oxidase (LAO), snake venommetalloproteinase (SVMP), vascular endothelial growth factor
(VEGF), serine protease (SP) or aminopeptidase (AMP). Molecular weight markers are shown on the left (base pairs).
doi:10.1371/journal.pntd.0004615.g004
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Fig 5. Multiple sequence alignment of elapid three-finger toxin amino acid sequences translated from transcripts
from VTRZ. Three-finger toxin amino acid sequences translated from transcripts isolated from the VTRZ of the elapid
species A. s. intermedius, A. l. cowlesi, A. l. lubricus andN. kaouthia. Cysteine residues are highlighted with carets.
Asterisks denote stop codon positions. Question marks denote unknown sequences. Black shading indicates identical
amino acids, grey shading indicates similar amino acids and white shading indicates unrelated amino acids.
doi:10.1371/journal.pntd.0004615.g005
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venom gland and by whatever sequence protocol used (Fig 6). The slight sequence differences
observed are likely a result of inter-individual sequence differences, as the venom was obtained
from a different set of B. arietans individuals than those used for the venom glands.
Discussion
Messenger RNA has been shown, using PCR-amplification techniques, to be present in the
venom or skin secretions of several venomous animals [24,25,27]. Whilst very encouraging
with respect to using venom for transcriptomic studies, we were concerned that the transcript-
amplification prowess of PCR may have overstated the ability of mRNA to remain stable in
venom, which contains several nucleases. In this study, we therefore decided to determine the
quantity and protein-encoding integrity of venom mRNA.
We first demonstrated that RNA recovered from lyophilized venom (VLYO) was in fact
extensively degraded. We therefore modified the experimental approach, by omitting the
lyophilization step and instead treating venom with TRIzol immediately after extraction
(VTRZ). We show here that the complete coding regions of the transcripts can be PCR ampli-
fied from both VLYO and VTRZ samples (Fig 2), but with considerably more success from the
VTRZ samples. This represents the first case of the PCR amplification of the entirety of the cod-
ing sequence for several transcripts from snake venom. In combination, the Bioanalyzer and
PCR results suggest that Bioanalyzer electropherograms alone can, with some confidence, be
used to discern the protein-encoding integrity of venom mRNA.
We have also shown that venom can be stored in TRIzol for up to 48 hours at 4–19°C (and
for 8 hours at 37°C) at minimal cost to RNA degradation (Figs 3 and 4). We also demonstrated
that the RNA recovered using this approach is of sufficient quality to recover and characterise
Fig 6. Multiple sequence alignment of C-type lectin amino acid sequences from transcripts isolated from VTRZ and venom gland (PCR/
EST/NGS). Two separate alignments (A, B) of C-type lectin isoforms obtained from B. arietans venom (GenBank accession numbers
KU052363-KU052365) with those found via PCR from i) the venom gland (KU724122), ii) EST sequences ([6]), and iii) contigs assembled from
Illumina MiSeq reads, prepared and assembled as previously described [29] (KU724120, KU724121). Key: Expressed Sequencing Tags (EST);
Next generation sequencing (NGS). Asterisks denote stop codon positions. Question marks denote unknown sequences. Black shading
indicates identical amino acids, grey shading indicates similar amino acids and white shading indicates unrelated amino acids.
doi:10.1371/journal.pntd.0004615.g006
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multiple toxin isoforms using a PCR-based sequencing strategy (Fig 5). Finally, we also showed
that, at least in the case of the C-type lectins, the isoforms identified in venom represent those
derived from venom gland RNA (Fig 6). Taken together, our experimental approach facilitates
the investigation of toxin-encoding genes directly from secreted venom and thus allows for
the rapid acquisition of venom toxin sequence data for scientific and potential therapeutic
purposes.
That RNA quality remains high, irrespective of an increase in temperature or time, likely
explains why the majority of transcripts were successfully PCR amplified. These results suggest
that the incubation of venom in TRIzol helps to reduce degradation of RNA, including mRNA,
but that it comes at a duration-to-yield cost. For example, incubation of venom in TRIzol at
19°C for all durations resulted in a greater yield of high quality RNA than was possible from
VLYO, but as the incubation time increased the yield of total RNA decreased, although the qual-
ity remained stable. This is important, particularly for the collection of venom during field-
work, where access to adequate storage conditions or laboratory access for sample processing
are often very limited. Our study has identified the value of TRIzol processing of snake venom.
This therefore suggests that other similar products may also have comparable scientific bene-
fits, and will require the similar protocol-standardising analysis as performed here with TRIzol.
Considering the fact that snake venom contains a diverse array of destructive nucleases and
phosphodiesterases [37] and is an acidic environment [14,38], the apparent presence of mRNA
had originally been thought to be paradoxical [27]. Given that this environment is likely
destructive to RNA, it had been suggested that venom mRNAmay have unique properties that
prevented it from degradation. However, the increased quality and quantity of RNA recovered
from VTRZ over VLYO (Figs 1 and 2) suggests otherwise, indicating that the RNA recovered
from lyophilized venom is in fact extensively degraded. It is likely that any previously observed
success with PCR using VLYO is the result of the ability of PCR to amplify trace amounts of
residual RNA that have escaped degradation, or the amplification of fragments of specific tran-
scripts (and not the entire transcripts).
Here, we cloned and sequenced full-length venom transcripts from pooled elapid snake
venom, demonstrating that considerable isoform variability can be detected using our experi-
mental approach. Eighty-one novel 3FTX sequences were obtained (Fig 5). In addition, the
results also provided evidence that elapid venom contains RNA, as well as the first case of any
3FTX transcript being identified in snake venom. The successful amplification of equivalent C-
type lectin isoforms from both B. arietans venom and venom gland (Fig 6) suggests that the
isoforms detected from venom represent those found in the venom gland, regardless of how
they were acquired (conventional PCR, EST or NGS). In combination these observations sug-
gest that snake venom is a viable alternative to the venom gland as a source of both isoformic
diversity and venom-gland representative data.
Consequentially, toxin transcript expression can be monitored over time to detect changes
as a result of ontogenetic stages of development, diet or adaptation to captivity—issues that
likely effect antivenom efficacy—and which could not possibly be monitored if an animal had
to be sacrificed to obtain its RNA.
Our results provide a novel extension of the utility of venom derived mRNA, but working
with such samples is not without its limitations. Currently, the amount of RNA recovered from
the venom of a single snake is very low, and is far less than that required for current standard
NGS approaches (e.g. transcriptomics). The pooling of venom sourced frommany snakes of the
same species would reduce this limitation, but would of course impart its own set of limitations
on subsequent analysis, particularly given reports of intra-specific variation in venom composi-
tion [7–15]. RNA amplification could be employed to increase the levels of RNA to those
required for NGS, but this approach could introduce differential gene-amplification biases.
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Whilst acknowledging these limitations, it is also clear from the rapid technical advances in
RNA-recovery kits and RNA-sequencing platforms that it will not be long before RNA recov-
ered from TRIzol-treated venom samples will be the norm to ethically produce accurate venom
transcriptomics—for whatever biological purpose and from wherever the samples are collected.
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